Brief: Brain+ Gets Granted Full Approval To Lecanemab From US FDA
10/07/2023 10:45
July 10 (Reuters) - Brain+ A/S BRAINP.CO :
* US FDA HAS GRANTED FULL APPROVAL TO LECANEMAB, FIRST EVER
DISEASE MODIFYING TREATMENT FOR EARLY ALZHEIMER'S DISEASE
* RECENT INDUSTRY NEWS IS SEEN TO INCREASE COMPANY'S
POTENTIAL TO
ATTRACT CO-DEVELOPMENT PARTNERSHIPS
Source text for Eikon: ID:nWkrbzs0dN
Further company coverage: BRAINP.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))